Investor List:

Top Drug Delivery Seed Investors (109)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Omri Amirav Drory, General Partner at NFX
Omri Amirav Drory
NFX·General Partner
Sweet spot: $3.0M
Range: $500K - $5.0M
Investors in SF Bay Area (CA)
Photo of James Wang, General Partner at Creative Ventures
James Wang
Creative Ventures·General Partner
Sweet spot: $750K
Range: $250K - $1M
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in Chemicals (Series A), Investors in DeepTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Cybersecurity (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Milad Alucozai, Investor at BoxOne Ventures
Milad Alucozai
BoxOne Ventures·Investor
Sweet spot: $300K
Range: $100K - $1M
Investors in Boston (MA), Investors in Chicago (IL), Investors in Montreal, Investors in Toronto (Ontario), Investors in San Francisco (CA)
Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in SaaS (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Drug Delivery (Seed), Investors in Analytics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in Health & Hospital Services (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Health IT (Seed), Investors in Analytics (Seed), Investors in Digital Health (Seed), Investors in SaaS (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Hardware (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Analytics (Seed), Investors in SaaS (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in British Columbia (Other Lists), Investors in Midwest (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Anastasia Budinskaya, Associate at NFX
Anastasia Budinskaya
NFX·Associate
Sweet spot: $2.5M
Range: $500K - $5.0M
Investors in San Francisco (CA)
Photo of Ben York, Investor at Ensemble Brands
Ben York
Ensemble Brands·Investor
Sweet spot: $100K
Range: $50K - $250K
Photo of Peter Parker, Managing Partner at Mission BioCapital
Peter Parker
Mission BioCapital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)